Gene · 53369
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects. | Arterioscler Thromb Vasc Biol | 2021 | 34134520 | PubTator, text mining | PubMed |
| Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. | iScience | 2021 | 34124613 | PubTator, text mining | PubMed |
| Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside. | Biomedicines | 2021 | 34070542 | PubTator, text mining | PubMed |
| Distinct Fatty Acid Compositions of HDL Phospholipids Are Characteristic of Metabolic Syndrome and Premature Coronary Heart Disease-Family Study. | Int J Mol Sci | 2021 | 34066314 | PubTator, text mining | PubMed |
| Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease? | Biomedicines | 2021 | 34065648 | PubTator, text mining | PubMed |
| Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications. | J Clin Med | 2021 | 34063950 | PubTator, text mining | PubMed |
| APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population. | Arterioscler Thromb Vasc Biol | 2021 | 34039022 | PubTator, text mining | PubMed |
| Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment. | J Lipids | 2021 | 33996157 | PubTator, text mining | PubMed |
| Large HDL2 combined with inflammatory factors as superior predictors for coronary artery disease than small HDL3. | Ann Transl Med | 2021 | 33987370 | PubTator, text mining | PubMed |
| Long-term fasting improves lipoprotein-associated atherogenic risk in humans. | Eur J Nutr | 2021 | 33963431 | PubTator, text mining | PubMed |
| Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL). | Biol Chem | 2021 | 33934596 | PubTator, text mining | PubMed |
| Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity. | J Clin Med | 2021 | 33923393 | PubTator, text mining | PubMed |
| Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study. | Rheumatol Ther | 2021 | 33811316 | PubTator, text mining | PubMed |
| High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives. | Cells | 2021 | 33807918 | PubTator, text mining | PubMed |
| Inducible phospholipid transfer protein deficiency ameliorates atherosclerosis. | Atherosclerosis | 2021 | 33798923 | PubTator, text mining | PubMed |
| Arylesterase activity of paraoxonase 1 (PON1) on HDL3 and HDL2: Relationship with Q192R, C-108T, and L55M polymorphisms. | Biochem Biophys Rep | 2021 | 33778169 | PubTator, text mining | PubMed |
| The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes. | Curr Atheroscler Rep | 2021 | 33772657 | PubTator, text mining | PubMed |
| Changes in plasma HDL and its subcomponents HDL2b and HDL3 regulate inflammatory response by modulating SOCS1 signaling to affect severity degree and prognosis of sepsis. | Infect Genet Evol | 2021 | 33684569 | PubTator, text mining | PubMed |
| Obesity Affects HDL Metabolism, Composition and Subclass Distribution. | Biomedicines | 2021 | 33673728 | PubTator, text mining | PubMed |
| Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients. | Orphanet J Rare Dis | 2021 | 33640001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53369/papers?page=14